HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wei-Heng Xu Selected Research

Wei-Heng Xu Research Topics

Disease

5Neoplasms (Cancer)
09/2022 - 10/2016
3Fibrosis (Cirrhosis)
07/2022 - 08/2014
2Colitis
09/2022 - 07/2022
2Sepsis (Septicemia)
06/2022 - 12/2016
2Hepatocellular Carcinoma (Hepatoma)
01/2017 - 11/2016
2Liver Neoplasms (Liver Cancer)
01/2017 - 11/2016
1Dementia (Dementias)
09/2022
1Ulcerative Colitis
07/2022
1Disease Progression
07/2022
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
07/2022
1Weight Loss (Weight Reduction)
07/2022
1Inflammation (Inflammations)
12/2016
1Endotoxemia
12/2016
1Liver Cirrhosis (Hepatic Cirrhosis)
08/2014

Drug/Important Bio-Agent (IBA)

3MatrinesIBA
07/2022 - 11/2016
2Pharmaceutical PreparationsIBA
09/2022 - 01/2017
2Dextran SulfateIBA
09/2022 - 07/2022
2matrine derivate masmIBA
07/2022 - 12/2016
2Biomarkers (Surrogate Marker)IBA
06/2022 - 11/2016
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
09/2022
1polydatinIBA
09/2022
1AcidsIBA
09/2022
1cryptotanshinoneIBA
07/2022
1CollagenIBA
07/2022
1DiterpenesIBA
07/2022
1SuspensionsIBA
01/2017
1AlkaloidsIBA
01/2017
1Messenger RNA (mRNA)IBA
11/2016
1Proteins (Proteins, Gene)FDA Link
11/2016
1Doxorubicin (Adriamycin)FDA LinkGeneric
11/2016
1Epithelial Cell Adhesion MoleculeIBA
11/2016
1CateninsIBA
11/2016
1anthraceneIBA
08/2014
1ThionesIBA
08/2014
1ribosomal protein S5IBA
08/2014

Therapy/Procedure

2Therapeutics
11/2016 - 10/2016
1Ligation
12/2016
1Punctures
12/2016